Concord Drugs Market Cap ($11.26M USD)
Concord Drugs Market Cap ($11.26M USD). As of Oct. 6, 2026, Concord Drugs (CONCORD) market capitalisation is ₹101.30 Cr ($11.26M), with 1.39 Cr shares outstanding at a current price of ₹73.03 on BSE, ranking 3123 out of 5368 companies by market cap in our screener. Concord Drugs operates in the Healthcare sector and is classified as a Small Cap stock. Examine CONCORD earnings for recent quarterly revenue, profit and EPS trends.
Market Cap History of Concord Drugs (Last 10 Years)
CONCORD market capitalisation from year-end BSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Concord Drugs share price today.
End of Year Market Cap History — Concord Drugs
CONCORD year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. Compare with CONCORD fair value to assess whether the stock is under or overvalued.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹101.30 Cr
$11.26M USD
|
₹73.03 | BSE | -11.46% |
| 2025 |
₹114.41 Cr
$12.71M USD
|
₹82.48 | BSE | +118.78% |
| 2024 |
₹52.29 Cr
$5.81M USD
|
₹37.70 | BSE | -36.87% |
| 2023 |
₹82.84 Cr
$9.20M USD
|
₹59.72 | BSE | +83.47% |
| 2022 |
₹45.15 Cr
$5.02M USD
|
₹32.55 | BSE | +1.24% |
| 2021 |
₹44.60 Cr
$4.96M USD
|
₹32.15 | BSE | +40.39% |
| 2020 |
₹31.76 Cr
$3.53M USD
|
₹22.90 | BSE | +52.67% |
| 2019 |
₹20.81 Cr
$2.31M USD
|
₹15.00 | BSE | -33.63% |
| 2018 |
₹31.35 Cr
$3.48M USD
|
₹22.60 | BSE | -29.37% |
| 2017 |
₹44.39 Cr
$4.93M USD
|
₹32.00 | BSE | -34.69% |
| 2016 |
₹67.97 Cr
$7.55M USD
|
₹49.00 | BSE | -17.72% |
| 2015 |
₹82.60 Cr
$9.18M USD
|
₹59.55 | BSE | - |